British researchers found that neuroleptics -- including haloperidol and risperidone -- did not provide any long-term benefits for most Alzheimer's patients with mild behavioral symptoms and were linked to a noticeable impairment in verbal skills. A representative of the Alzheimer's Research Trust said the results underscore the need for better treatments for the disease.

Full Story:

Related Summaries